SynthesisPloS one2025

Efficacy and safety of antifibrotic drugs for interstitial lung diseases other than IPF: A systematic review, meta-analysis and trial sequential analysis.

Mei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.